Maes RA - Search Results

1

Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times.

De Bruijn EA, Sleeboom HP, van Helsdingen PJ, van Oosterom AT, Tjaden UR, Maes RA. De Bruijn EA, et al. Among authors: maes ra. Int J Cancer. 1992 May 28;51(3):359-64. doi: 10.1002/ijc.2910510305. Int J Cancer. 1992. PMID: 1592527 Clinical Trial.

2

Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.

Van Der Heyden SA, Highley MS, De Bruijn EA, Tjaden UR, Reeuwijk HJ, Van Slooten H, Van Oosterom AT, Maes RA. Van Der Heyden SA, et al. Among authors: maes ra. Br J Clin Pharmacol. 1999 Apr;47(4):351-6. doi: 10.1046/j.1365-2125.1999.00899.x. Br J Clin Pharmacol. 1999. PMID: 10233196 Free PMC article.

3

Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Highley MS, van Oosterom AT, Maes RA, De Bruijn EA. Highley MS, et al. Among authors: maes ra. Clin Pharmacokinet. 1999 Jul;37(1):59-73. doi: 10.2165/00003088-199937010-00004. Clin Pharmacokinet. 1999. PMID: 10451783 Review.

4

Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study.

Dumez H, Martens M, Selleslach J, Guetens G, De Boeck G, Aerts R, De Bruijn EA, Maes RA, van Oosterom AT. Dumez H, et al. Among authors: maes ra. Anticancer Drugs. 2007 Feb;18(2):211-8. doi: 10.1097/CAD.0b013e328010ee5c. Anticancer Drugs. 2007. PMID: 17159607 Clinical Trial.

5

Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatography.

Zhang ZD, Guetens G, De Boeck G, Van Cauwenberghe K, Maes RA, Ardiet C, van Oosterom AT, Highley M, de Bruijn EA, Tjaden UR. Zhang ZD, et al. Among authors: maes ra. J Chromatogr B Biomed Sci Appl. 2000 Mar 10;739(2):281-9. doi: 10.1016/s0378-4347(99)00561-7. J Chromatogr B Biomed Sci Appl. 2000. PMID: 10755372

6

Fluorouracil catabolism in the combination treatment of cyclophosphamide, methotrexate and fluorouracil.

De Bruijn EA, Van der Heyden SA, Gheuens EE, Maes RA. De Bruijn EA, et al. Among authors: maes ra. Jpn J Cancer Res. 1992 Oct;83(10):1102-7. doi: 10.1111/j.1349-7006.1992.tb02728.x. Jpn J Cancer Res. 1992. PMID: 1452462 Free PMC article.

7

Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.

De Pooter CM, Van Oosterom AT, Scalliet PG, Maes RA, de Bruijn EA. De Pooter CM, et al. Among authors: maes ra. Biochem Pharmacol. 1996 Mar 8;51(5):629-34. doi: 10.1016/s0006-2952(95)02229-5. Biochem Pharmacol. 1996. PMID: 8615899

8

P-glycoprotein: clinical significance and methods of analysis.

van der Heyden S, Gheuens E, DeBruijn E, Van Oosterom A, Maes R. van der Heyden S, et al. Crit Rev Clin Lab Sci. 1995;32(3):221-64. doi: 10.3109/10408369509084685. Crit Rev Clin Lab Sci. 1995. PMID: 7495497 Review.

9

Nanotechnology in bio/clinical analysis.

Guetens G, Van Cauwenberghe K, De Boeck G, Maes R, Tjaden UR, van der Greef J, Highley M, van Oosterom AT, de Bruijn EA. Guetens G, et al. J Chromatogr B Biomed Sci Appl. 2000 Feb 28;739(1):139-50. doi: 10.1016/s0378-4347(99)00553-8. J Chromatogr B Biomed Sci Appl. 2000. PMID: 10744322 Review.

10

Angiogenesis: possibilities for therapeutic interventions.

Wynendaele W, van Oosterom AT, Pawinski A, de Bruijn EA, Maes RA. Wynendaele W, et al. Among authors: maes ra. Pharm World Sci. 1998 Dec;20(6):225-35. doi: 10.1023/a:1008600603059. Pharm World Sci. 1998. PMID: 9972522 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page